Bosutris 500 mg Tablets Bosutris 500 mg Tablets contain bosutinib, a targeted anticancer medicine used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). It works by blocking abnormal tyrosine kinase proteins that stimulate the growth and survival of leukemia cells. By interrupting these signals, the medicine helps reduce the number of abnormal blood cells and supports long-term control of the disease.

Effects & Benefits Helps slow the growth and multiplication of leukemia cells. Used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Helps control abnormal white blood cell production. May reduce the progression of leukemia in eligible patients. Supports improved long-term disease management when taken consistently. Can be used when recommended by a hematology or oncology specialist. Possible Side Effects

Like all medicines, Bosutris 500 mg Tablets may cause side effects, although not everyone experiences them